Clinical Trial Update: Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive E2007 (perampanel) for refractory partial seizures has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Seizures

Drugs mentioned

• E2007 (perampanel) (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Refractory Partial Seizures | Phase 3 | Status: COMPLETED | Results posted: 2013-02-05